Plain-English translation of NCT06571136 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at N5 Sensors have developed a device that can detect tiny amounts of chemicals in your breath. This trial will test whether measuring specific chemicals in exhaled breath can reliably identify whether someone has COVID-19. If successful, this could become a quick, simple way to detect COVID infection without needles or uncomfortable swabs.
Current COVID tests (like nasal swabs) require close contact with healthcare workers and can be uncomfortable. If breath analysis works, it could offer a faster, easier, and potentially more convenient way for people to find out if they have COVID-19.
You likely qualify if…
You likely don't qualify if…
You will visit the research site where you'll breathe into a special device to provide an exhaled breath sample. Researchers will also collect a nasal mucus sample using a swab to test for COVID-19. Your breath measurements will then be compared to your nasal test results to see if the breath analysis can accurately detect COVID infection. The study is enrolling about 60 people total, both those with and without COVID-19.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States
Sponsor
N5 Sensors
Collaborators
Providence Health & Services, U.S. Department of Homeland Security
Enrollment target
~60 participants
Started
August 2024
Primary completion
February 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Becca Watson, BS
N5 Sensors
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.